Literature DB >> 3136960

Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes.

M G Roncarolo1, M Zoppo, R Bacchetta, C Gabiano, C Sacchetti, F Cerutti, P A Tovo.   

Abstract

In the present study, we investigated the interleukin-2 (IL-2) production and the proliferative responses by peripheral blood mononuclear cells (PBMNC) of 23 children suffering from insulin-dependent diabetes mellitus (IDDM). In addition, the presence of circulating activated T lymphocytes expressing the interleukin-2 receptor (IL-2 R) and HLA-DR antigens was evaluated. The patients were tested at hospital admittance, before starting insulin treatment. Decreased IL-2 production by phytohemagglutinin (PHA)-activated PBMNC of IDDM patients was observed when compared to normal donors. In contrast, the proliferative responses of PBMNC to PHA and Con A were in the normal range. The expression of IL-2 R on patient's lymphocytes was not different from that observed in normal donors, whereas the relative and absolute number of HLA-DR+ T cells was increased. These results confirm the presence in IDDM patients of an imbalanced cellular immune response and demonstrate that the IL-2 deficiency is already present at the diagnosis and is not correlated with insulin administration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136960     DOI: 10.1016/0090-1229(88)90094-3

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  7 in total

1.  Molecular-genetic characterization of common, noncoding UBASH3A variants associated with type 1 diabetes.

Authors:  Yan Ge; Patrick Concannon
Journal:  Eur J Hum Genet       Date:  2018-02-28       Impact factor: 4.246

2.  Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Jennifer S Herrick; Gabriella Torres-Mejia; Esther M John; Anna R Giuliano; Lisa M Hines; Mariana C Stern; Kathy B Baumgartner; Angela P Presson; Roger K Wolff
Journal:  Carcinogenesis       Date:  2014-03-26       Impact factor: 4.944

Review 3.  Central role for interleukin-2 in type 1 diabetes.

Authors:  Maigan A Hulme; Clive H Wasserfall; Mark A Atkinson; Todd M Brusko
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

4.  Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.

Authors:  Yasar Dogan; Saadet Akarsu; Bilal Ustundag; Erdal Yilmaz; Metin Kaya Gurgoze
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 5.  Mechanisms of human FoxP3+ Treg cell development and function in health and disease.

Authors:  M Attias; T Al-Aubodah; C A Piccirillo
Journal:  Clin Exp Immunol       Date:  2019-04-01       Impact factor: 4.330

6.  Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis.

Authors:  K P Wandinger; K Wessel; P Neustock; A Siekhaus; H Kirchner
Journal:  J Neurol Sci       Date:  1997-07       Impact factor: 3.181

Review 7.  Updates on Immune Therapies in Type 1 Diabetes.

Authors:  Bimota Nambam; Michael J Haller
Journal:  Eur Endocrinol       Date:  2016-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.